Clinical Trials Administrator Archives – January 1, 2005
January 1, 2005
View Issues
-
After a quarter century, the Belmont Report holds up as ethical framework
Despite its relative brevity, the Belmont Report has withstood the test of time as a framework for ethical decision making about human subjects research, experts in research ethics say. -
OHRP director discusses Belmont Report impact
Clinical Trials Administrator asked Bernard Schwetz, DVM, PHD, director of the Office of Human Research Protections (OHRP) to discuss the Belmont Reports successes and challenges as the 25th anniversary of its launching has passed. Schwetz offers his views in this Q&A. -
Practice better closeout management in trials
Clinical trials administrators and other research staff could avoid common problems after research has been completed if they would follow a well-defined, closeout process, regardless of the type of award that was made, according to a research expert. -
Has FDP really improved research bureaucracy?
The Federal Demonstration Partnerships (FDP) latest incarnation in its nearly 20 years has the goal of reducing administrative burden in research and reducing bureaucracy, lofty objectives that clinical trial administrators and others could be forgiven for greeting with skepticism. -
FDP members want more improvements
Members of the Federal Demonstration Partnership (FDP) are aiming high in their latest efforts at improving efficiencies and reducing unnecessary paperwork during research. -
Willingness to participate in trials varies by race
Non-Caucasian cancer patients, while just as interested as Caucasian patients in learning about clinical trials, approach their decision to enroll in one differently, according to new study.